JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung Cancers

Molecular Cancer Therapeutics
Sean P PitrodaNikolai Khodarev

Abstract

Lung cancer is the leading cause of cancer-related deaths worldwide. Approximately 85% of all lung cancers are non-small cell histology [non-small cell lung cancer (NSCLC)]. Modern treatment strategies for NSCLC target driver oncogenes and immune checkpoints. However, less than 15% of patients survive beyond 5 years. Here, we investigated the effects of SAR302503 (SAR), a selective JAK2 inhibitor, on NSCLC cell lines and tumors. We show that SAR is cytotoxic to NSCLC cells, which exhibit resistance to genotoxic therapies, such as ionizing radiation, cisplatin, and etoposide. We demonstrate that constitutive IFN-stimulated gene expression, including an IFN-related DNA damage resistance signature, predicts for sensitivity to SAR. Importantly, tumor cell-intrinsic expression of PD-L1 is IFN-inducible and abrogated by SAR. Taken together, these findings suggest potential dual roles for JAK2 inhibitors, both as a novel monotherapy in NSCLCs resistant to genotoxic therapies, and in tandem with immune checkpoint inhibition. Mol Cancer Ther; 17(4); 732-9. ©2018 AACR.

References

Feb 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nikolai N KhodarevRalph R Weichselbaum
Aug 18, 2005·Bioinformatics·Aik Choon TanDonald Geman
Nov 1, 2008·Cancer Gene Therapy·H J MauceriR R Weichselbaum
Nov 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ralph R WeichselbaumAndy J Minn
Feb 18, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yunguang SunBo Lu
Sep 15, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lewis C CantleyPatricia S Steeg
Sep 18, 2012·Cell·Ramaswamy GovindanRichard K Wilson
May 21, 2013·BMC Genomics·Luigi MarchionniJeffrey T Leek
Mar 4, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sara C Meyer, Ross L Levine
May 3, 2014·Seminars in Oncology·Hyeonjoo CheonGeorge R Stark
Jan 1, 2013·Journal for Immunotherapy of Cancer·Stefani Spranger, Thomas Gajewski
Aug 27, 2014·International Journal of Cancer. Journal International Du Cancer·Iryna KolosenkoAngelo De Milito
Jan 15, 2015·Annual Review of Medicine·John J O'SheaArian Laurence
Mar 11, 2015·Nature·Christina Twyman-Saint VictorAndy J Minn
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
May 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-Charles SoriaScott Gettinger
May 28, 2015·Cancer Immunology Research·Eliezer M Van AllenDavid A Barbie
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Jun 28, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Fei ZhouCaicun Zhou
Aug 19, 2015·Journal of Translational Medicine·Rajesh MukthavaramSantosh Kesari
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Oct 16, 2015·BMC Cancer·James A BonnerEddy S Yang
Nov 26, 2015·Trends in Immunology·Andy J Minn
Dec 17, 2015·Advances in Experimental Medicine and Biology·Lindsey A TorreAhmedin Jemal
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 18, 2017·Nature Reviews. Clinical Oncology·Ralph R WeichselbaumYang-Xin Fu
Mar 25, 2017·Molecular Cancer Therapeutics·Stuart W EmberErnst Schönbrunn
May 13, 2017·Cell Reports·Angel Garcia-DiazAntoni Ribas

❮ Previous
Next ❯

Citations

Apr 5, 2020·Nature Reviews. Clinical Oncology·Khashayar EsfahaniLeonard Calabrese
Feb 20, 2020·Journal of Cellular Physiology·Arezoo HosseiniBehzad Baradaran
Jul 2, 2020·OncoTargets and Therapy·Shuya LiuJingbo Wu
Dec 18, 2019·Nature Communications·Khadijah A MitchellBríd M Ryan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Biomechanics

Biomechanics examines the generation of internal forces within the body and investigates the effects and control of forces that act on or are produced on tissues. Here are the latest discoveries.